These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4662616)

  • 1. Intravenous infusion of a standardised coagulation active phospholipid complex in uremic coagulation deficiency. Return to normal of thrombin generation and prothrombin consumption.
    Schimpf K; Hanf-Hoppe HW; Immich H
    Thromb Diath Haemorrh; 1972 Jul; 27(3):554-8. PubMed ID: 4662616
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravenous infusion of a standard coagulation-active phospholipid complex in uremic tendency to bleeding. Normalization of thrombin formation and prothrombin consumption].
    Schimpf K; Hanf-Hoppe HW; Immich H
    Med Welt; 1972 Sep; 23(37):1258-60. PubMed ID: 5078657
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitor of human blood coagulation elicited by thrombin.
    Marciniak E
    J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.
    Shuman MA; Levine SP
    J Clin Invest; 1980 Feb; 65(2):307-13. PubMed ID: 6243308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of oral contraceptives on the time-integral of thrombin generation (thrombin potential).
    Rotteveel RC; Roozendaal KJ; Eijsman L; Hemker HC
    Thromb Haemost; 1993 Dec; 70(6):959-62. PubMed ID: 8165618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
    Sultan Y; Loyer F
    J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased thrombin generation in patients with chronic renal failure.
    Sagripanti A; Cozza V; Baicchi U; Camici M; Cupisti A; Barsotti G
    Int J Clin Lab Res; 1997; 27(1):72-5. PubMed ID: 9144032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the action of factor VIIa in dilutional coagulopathy.
    Monroe DM
    Thromb Res; 2008; 122 Suppl 1():S7-S10. PubMed ID: 18691504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do we need thrombin generation assays for monitoring anticoagulation?
    Dempfle CE; Borggrefe M
    Thromb Haemost; 2008 Aug; 100(2):179-80. PubMed ID: 18690334
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs.
    Martini WZ; Dubick MA; Wade CE; Holcomb JB
    Crit Care Med; 2007 Jun; 35(6):1568-74. PubMed ID: 17452929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin.
    Prowse CV; Boffa MC; Guthrie C; Pepper DS
    Thromb Haemost; 1980 Feb; 42(5):1368-77. PubMed ID: 7368144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of prothrombin, thrombin and its receptors in human scars.
    Artuc M; Hermes B; Algermissen B; Henz BM
    Exp Dermatol; 2006 Jul; 15(7):523-9. PubMed ID: 16761961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients.
    Keularts IM; Hamulyak K; Hemker HC; Béguin S
    Thromb Haemost; 2000 Oct; 84(4):638-42. PubMed ID: 11057863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for analyzing the formation of thrombin in vessels.
    Chung TW; O'Rear EA
    Comput Biol Med; 1994 Jan; 24(1):31-41. PubMed ID: 8205790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets and phospholipids in tissue factor-initiated thrombin generation.
    Butenas S; Branda RF; van't Veer C; Cawthern KM; Mann KG
    Thromb Haemost; 2001 Aug; 86(2):660-7. PubMed ID: 11522019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uremic coagulopathy. Role of thrombin].
    Camici M; Sagripanti A
    Minerva Urol Nefrol; 2000 Jun; 52(2):67-72. PubMed ID: 11085063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.